IJMS | Free Full-Text | Uric Acid in Inflammation and the Pathogenesis of Atherosclerosis
Rasburicase represents a new tool for hyperuricemia in tumor lysis syndrome and in gout
Mechanism of Action | ELITEK® (rasburicase)
Everything You Need to Know about Tumor Lysis Syndrome — tl;dr pharmacy
Purine catabolic pathway and site of action of allopurinol and rasburicase. | Download Scientific Diagram
PharmGKB summary: uric acid-lowering drugs pathway, pharmacodynamics. - Abstract - Europe PMC
Biomedicines | Free Full-Text | Tumor Lysis Syndrome: An Endless Challenge in Onco-Nephrology
Management of Rasburicase-Induced Hemolytic Anemia
Update on the prevention and treatment of tumor lysis syndrome - Krishna Sury, 2019
Mechanism of action: rasburicase and allopurinol. Depicted is the... | Download Scientific Diagram
How does Allopurinol work? | Medicine Specifics
PPT - Allison Weddington, PharmD PGY1 Pharmacy Resident St. Louis Children's Hospital November 14, 2011 PowerPoint Presentation - ID:5660602
Mechanism of action: rasburicase and allopurinol. Depicted is the... | Download Scientific Diagram
Fig02 - Key Opinions in Medicine
Rasburicase: potential role in managing tumor lysis in patients with hematological malignancies - Document - Gale Academic OneFile
Rasburicase | SpringerLink
TLS — HaemBase
28. HYPERURICEMIA | Nurse Key
Mechanism of Action | ELITEK® (rasburicase)
American Society of Pediatric Nephrology on Twitter: "Tumor Lysis Syndrome: Allopurinol vs Rasburicase #Nephpearls #IMpearls https://t.co/qyPAkT3lzK https://t.co/bH9aXBS8WS @edgarvlermamd" / Twitter
Elitek™–rasburicase: an effective means to prevent and treat hyperuricemia associated with tumor lysis syndrome, a Meeting Report, Dallas, Texas, January 2002 | Leukemia
Purine catabolism and mechanisms of action of allopurinol and... | Download Scientific Diagram
Pulsenotes | Tumour lysis syndrome notes
Tumor lysis syndrome: A clinical review
Chapter 4: Tumor Lysis Syndrome
Figure 1 from Urate oxidase (rasburicase) for treatment of severe tophaceous gout. | Semantic Scholar
